A modulator of NRG1 for treatment of respiratory disorders

Details for Australian Patent Application No. 2008292262 (hide)

Owner Novartis AG

Inventors Jackson, Alan; Jones, Carol Elizabeth

Agent Davies Collison Cave

Pub. Number AU-B-2008292262

PCT Pub. Number WO2009/027332

Priority 07114972.8 24.08.07 EP

Filing date 22 August 2008

Wipo publication date 5 March 2009

Acceptance publication date 31 May 2012

International Classifications

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/027332 Priority application(s): WO2009/027332

31 May 2012 Application Accepted

  Published as AU-B-2008292262

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008292264-Reduction of dimer content in factor VII polypeptide compositions by heat treatment

2008292255-Set for producing an offset resurfacing condyle cap implant for an artificial hip joint